Company registration number 03921428 (England and Wales)
LOVANIA NURSERIES LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
LOVANIA NURSERIES LIMITED
COMPANY INFORMATION
Directors
Mrs K C Ball
Mr I Land
Mr J G Ball
(Appointed 17 January 2025)
Secretary
Mrs K C Ball
Company number
03921428
Registered office
188 Blackgate Lane
Tarleton
Preston
Lancashire
PR4 6UU
Auditor
JS. Audit Limited
James House
Stonecross Business Park
Yew Tree Way
Warrington
Cheshire
WA3 3JD
Business address
188 Blackgate Lane
Tarleton
Preston
Lancashire
PR4 6UU
LOVANIA NURSERIES LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Group statement of comprehensive income
7
Group balance sheet
8
Company balance sheet
9
Group statement of changes in equity
10
Company statement of changes in equity
11
Group statement of cash flows
12
Notes to the financial statements
13 - 31
LOVANIA NURSERIES LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -
The directors present the strategic report for the year ended 31 December 2024.
Review of the Business
Poor weather during the peak sales months of 2024 impacted Lovania’s season (and the sector more broadly), leading to a drop in sales from £17,148k to £14,631k, and a reduction in operating profit from £113k to a loss of £449k. It is difficult to mitigate the impact of poor weather on outdoor sales; however, Lovania has responded to a challenging year by implementing measures aimed at optimising operational efficiencies, improving cost control and maintaining strong customer relationships, which will be crucial as market conditions improve.
For 2025, the Company plans to invest in a new transplanter to improve production efficiency, reduce costs and improve quality consistency. Furthermore, the Company has benefited from newly developed outdoor growing space in 2025, which will improve quality during warmer months.
Additionally, the company is further enhancing its management information systems in 2025 and 2026 to ensure that it remains competitive and well-prepared for the opportunities ahead.
The directors are confident that strategic and operational improvements made in 2025 will contribute to a stronger and more resilient Lovania in the years to come.
Key Performance Indicators
The Key Performance Indicators used to monitor business performance include:
Daily sales reporting
Daily cash flow monitoring
Weekly payroll reporting against budget and prior year
Monthly sales and gross margin reporting by class of product and customer
Preparation of full monthly management accounts including profit and loss account, cost centre and balance sheet reporting against budget and prior year
Stock holding
Principal Risks and Uncertainties
The directors recognise that managing risks is integral to achieving sustainable growth and safeguarding the interests of our customers, suppliers, staff, shareholders and stakeholders. Key risk mitigations include:
Comprehensive insurance to cover known risks
Training and development of staff to ensure continuity and strengthen our teams
Diversification of the customer base to avoid reliance on a single customer
Continued accreditation with OHAS to demonstrate suitable quality management procedures
Cybersecurity protocols and deployment of firewalls, intrusion detection systems, and antivirus software to safeguard the company's network infrastructure from unauthorised access and malware
Investment in research to develop effective and sustainable peat-free compost alternatives, aiming to reduce environmental impacts and promote sustainable gardening practices
Mrs K C Ball
Director
29 September 2025
LOVANIA NURSERIES LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
The directors present their annual report and financial statements for the year ended 31 December 2024.
Principal activities
The principal activity of the company and group continued to be that of a horticultural grower.
Results and dividends
The results for the year are set out on page 7.
Ordinary dividends were paid amounting to £67,975. The directors do not recommend payment of a further dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr K J Ball
(Resigned 13 March 2025)
Mrs K C Ball
Mr I Land
Mr L Chambers
(Resigned 24 December 2024)
Mr J G Ball
(Appointed 17 January 2025)
Financial instruments
The group uses various financial instruments as part of its operational and financial risk management framework. These primarily include cash and cash equivalents, trade receivables, trade payables, and loans. The purpose of these instruments is to manage the group’s exposure to liquidity, credit, and interest rate risks.
Future developments
The group continues to invest in machinery and equipment to improve efficiencies on the nurseries and help mitigate the impact of rising costs. The broader business strategy is to consolidate production across fewer, larger sites. In addition, the group is engaged in various research and development projects, particularly in relation to peat free growing media. Indeed, the group is part of a fellowship of leading growers working to transition to peat free production in the near future.
Auditor
The auditor, JS. Audit Limited, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
LOVANIA NURSERIES LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
Statement of directors' responsibilities
The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the group and company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Strategic report
The truegroup has chosen in accordance with Companies Act 2006, s.414C(11) to set out in the group's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.
On behalf of the board
Mrs K C Ball
Director
29 September 2025
LOVANIA NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF LOVANIA NURSERIES LIMITED
- 4 -
Opinion
We have audited the financial statements of Lovania Nurseries Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the group's and the parent company's affairs as at 31 December 2024 and of the group's loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
The information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
The strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
LOVANIA NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF LOVANIA NURSERIES LIMITED
- 5 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement included within the directors' report, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities and fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities including fraud is detailed below.
Based on our understanding of the company and sector, we identified that the principal risks of non-compliance with laws and regulations related to, but were not limited to, the Companies Act 2006, UK tax, employment, pension and health and safety legislation and we considered the extent to which non-compliance might have a material effect on the financial statements. We also considered those laws and regulations that have a direct impact on the preparation of the financial statements such as the Companies Act 2006.
We evaluated management’s incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls) and determined that the principal risks were related to management bias in accounting estimates and judgements and the risk of fraud in revenue recognition.
LOVANIA NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF LOVANIA NURSERIES LIMITED
- 6 -
Our procedures to respond to risks identified included the following:
reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;
enquiring of management about actual and potential litigation and claims, their policies and procedures to prevent and detect fraud as well as whether they have knowledge of any actual, suspected or alleged fraud;
performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;
obtaining an understanding of provisions and holding discussions with management to understand the basis of recognition or non-recognition of tax provisions;
reviewing the basis of valuation for stock and reviewing post year end activity to determine the net realisable value; and
in addressing the risk of fraud through management override of controls: testing the appropriateness of journal entries; assessing whether the accounting estimates, judgements and decisions made by management are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.
We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.
There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Christopher Moss BSc F.C.A. (Senior Statutory Auditor)
For and on behalf of JS. Audit Limited, Statutory Auditor
Chartered Accountants
James House
Stonecross Business Park
Yew Tree Way
Warrington
Cheshire
WA3 3JD
30 September 2025
LOVANIA NURSERIES LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
2024
2023
Notes
£
£
Turnover
3
14,630,807
17,148,459
Cost of sales
(11,646,456)
(13,386,994)
Gross profit
2,984,351
3,761,465
Administrative expenses
(3,756,294)
(4,075,618)
Other operating income
322,869
426,827
Operating (loss)/profit
4
(449,074)
112,674
Interest receivable and similar income
7
872
3,549
Interest payable and similar expenses
8
(237,514)
(212,169)
Loss before taxation
(685,716)
(95,946)
Tax on loss
9
71,247
3,034
Loss for the financial year
(614,469)
(92,912)
Loss for the financial year is all attributable to the owners of the parent company.
Total comprehensive income for the year is all attributable to the owners of the parent company.
The profit and loss account has been prepared on the basis that all operations are continuing operations.
The notes on pages 13 to 31 form part of these financial statements.
LOVANIA NURSERIES LIMITED
GROUP BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 8 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
11
11,104
17,984
Tangible assets
12
5,233,070
5,344,202
Investments
13
550,000
550,000
5,794,174
5,912,186
Current assets
Stocks
15
2,160,562
2,392,353
Debtors
16
1,860,477
1,516,949
Cash at bank and in hand
2,958
138,486
4,023,997
4,047,788
Creditors: amounts falling due within one year
17
(4,816,041)
(4,441,557)
Net current liabilities
(792,044)
(393,769)
Total assets less current liabilities
5,002,130
5,518,417
Creditors: amounts falling due after more than one year
18
(1,776,526)
(1,539,122)
Provisions for liabilities
Deferred tax liability
21
223,647
294,894
(223,647)
(294,894)
Net assets
3,001,957
3,684,401
Capital and reserves
Called up share capital
23
2
2
Profit and loss reserves
24
3,001,955
3,684,399
Total equity
3,001,957
3,684,401
The notes on pages 13 to 31 form part of these financial statements.
The financial statements were approved by the board of directors and authorised for issue on 29 September 2025 and are signed on its behalf by:
29 September 2025
Mrs K C Ball
Director
Company registration number 03921428 (England and Wales)
LOVANIA NURSERIES LIMITED
COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 9 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
11
11,104
17,984
Tangible assets
12
4,839,465
4,953,396
Investments
13
550,100
550,100
5,400,669
5,521,480
Current assets
Stocks
15
1,907,545
2,144,242
Debtors
16
2,029,956
1,635,367
Cash at bank and in hand
2,859
125,106
3,940,360
3,904,715
Creditors: amounts falling due within one year
17
(4,581,839)
(4,250,566)
Net current liabilities
(641,479)
(345,851)
Total assets less current liabilities
4,759,190
5,175,629
Creditors: amounts falling due after more than one year
18
(1,364,281)
(1,103,305)
Provisions for liabilities
Deferred tax liability
21
239,082
297,281
(239,082)
(297,281)
Net assets
3,155,827
3,775,043
Capital and reserves
Called up share capital
23
2
2
Profit and loss reserves
24
3,155,825
3,775,041
Total equity
3,155,827
3,775,043
The notes on pages 13 to 31 form part of these financial statements.
As permitted by s408 of the Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s loss for the year was £551,241 (2023: £82,235 loss).
The financial statements were approved by the board of directors and authorised for issue on 29 September 2025 and are signed on its behalf by:
29 September 2025
Mrs K C Ball
Director
Company registration number 03921428 (England and Wales)
LOVANIA NURSERIES LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2023
2
3,796,733
3,796,735
Year ended 31 December 2023:
Loss and total comprehensive income
-
(92,912)
(92,912)
Dividends
10
-
(19,422)
(19,422)
Balance at 31 December 2023
2
3,684,399
3,684,401
Year ended 31 December 2024:
Loss and total comprehensive income
-
(614,469)
(614,469)
Dividends
10
-
(67,975)
(67,975)
Balance at 31 December 2024
2
3,001,955
3,001,957
The notes on pages 13 to 31 form part of these financial statements.
LOVANIA NURSERIES LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 11 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2023
2
3,876,698
3,876,700
Year ended 31 December 2023:
Loss and total comprehensive income for the year
-
(82,235)
(82,235)
Dividends
10
-
(19,422)
(19,422)
Balance at 31 December 2023
2
3,775,041
3,775,043
Year ended 31 December 2024:
Profit and total comprehensive income
-
(551,241)
(551,241)
Dividends
10
-
(67,975)
(67,975)
Balance at 31 December 2024
2
3,155,825
3,155,827
The notes on pages 13 to 31 form part of these financial statements.
LOVANIA NURSERIES LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash (absorbed by)/generated from operations
30
(407,476)
908,910
Interest paid
(237,514)
(212,169)
Net cash (outflow)/inflow from operating activities
(644,990)
696,741
Investing activities
Purchase of intangible assets
(6,106)
(17,476)
Purchase of tangible fixed assets
(172,543)
(181,801)
Proceeds from disposal of tangible fixed assets
11,337
92
Interest received
872
3,549
Net cash used in investing activities
(166,440)
(195,636)
Financing activities
Proceeds from directors loans
394,747
-
Repayment of directors loans
(80,381)
-
Proceeds from new bank loans
1,600,000
900,000
Repayment of bank loans
(1,032,425)
(1,082,821)
Payment of finance leases obligations
(175,132)
(156,197)
Dividends paid to equity shareholders
(67,975)
(19,422)
Net cash generated from/(used in) financing activities
638,834
(358,440)
Net (decrease)/increase in cash and cash equivalents
(172,596)
142,665
Cash and cash equivalents at beginning of year
138,486
(4,179)
Cash and cash equivalents at end of year
(34,110)
138,486
Relating to:
Cash at bank and in hand
2,958
138,486
Bank overdrafts included in creditors payable within one year
(37,068)
-
The notes on pages 13 to 31 form part of these financial statements.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 13 -
1
Accounting policies
Company information
Lovania Nurseries Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is 188 Blackgate Lane, Tarleton, Preston, UK.
The group consists of Lovania Nurseries Limited and its subsidiary, Seiont Nurseries Limited.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
1.2
Business combinations
In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.
Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 14 -
1.3
Basis of consolidation
The consolidated group financial statements consist of the financial statements of the parent company Lovania Nurseries Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.
All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.
Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.
1.4
Going concern
The directors have prepared financial forecasts for a period up to 31 December 2026 which show improved profitability. After taking into account the group's financial forecasts, the directors have reasonable expectation that the group can continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparation of the financial statements.
1.5
Turnover
Turnover represents the total revenue generated from the sale of goods and services during the financial year. It is recognised when the significant risks and rewards of ownership have been transferred to the customer, the amount of revenue can be reliably measured, and it is probable that economic benefits will flow to the entity. The turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, and value added tax. It includes revenue from the sale of products and provision of services.
1.6
Intangible fixed assets - goodwill
Goodwill, being the excess of the amount paid in consideration over the net assets of the business acquired in 2015, is fully written off.
1.7
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Software
10% to 25% straight line
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 15 -
1.8
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:
Freehold buildings
2% straight line
Leasehold improvements
5% to 7% straight line
Plant and equipment
2% to 35% straight line
Fixtures and fittings
10% to 33% straight line
Computers
33% straight line
Motor vehicles
33% straight line
Freehold land and assets in the course of construction are not depreciated.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.
1.9
Fixed asset investments
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.10
Impairment of fixed assets
At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 16 -
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.11
Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
1.12
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.13
Financial instruments
The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.
1.14
Equity instruments
Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.
1.15
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 18 -
1.16
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.17
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.18
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Amounts payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.
1.19
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Judgements and key sources of estimation uncertainty
In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
The critical estimates made by the directors in preparing these financial statements relate to the useful economic life of tangible assets, of which depreciation rates are disclosed in Note 1.8, the recoverability of trade debtors and the valuation of stock.
The critical judgement made by the directors relates to their assessment of going concern in note 1.4.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 19 -
3
Turnover and other revenue
2024
2023
£
£
Turnover analysed by class of business
Sale of goods
14,630,807
17,148,459
2024
2023
£
£
Other revenue
Interest income
872
3,549
4
Operating (loss)/profit
2024
2023
£
£
Operating (loss)/profit for the year is stated after charging/(crediting):
Exchange gains
(18,476)
(4,403)
Fees payable to the group's auditor for the audit of the group's financial statements
10,750
9,650
Depreciation of owned tangible fixed assets
346,725
408,616
Depreciation of tangible fixed assets held under finance leases
96,223
148,361
(Profit)/loss on disposal of tangible fixed assets
(7,300)
22
Amortisation of intangible assets
12,986
28,625
Operating lease charges
59,665
22,932
5
Employees
The average monthly number of persons (including directors) employed by the group and company during the year was:
Group
Company
2024
2023
2024
2023
Number
Number
Number
Number
Employees
131
128
119
116
Directors
4
4
4
4
Total
135
132
123
120
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
5
Employees
(Continued)
- 20 -
Their aggregate remuneration comprised:
Group
Company
2024
2023
2024
2023
£
£
£
£
Wages and salaries
3,706,310
3,604,752
3,375,667
3,284,313
Social security costs
350,483
328,353
322,363
303,592
Pension costs
78,425
98,013
71,687
92,974
4,135,218
4,031,118
3,769,717
3,680,879
6
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
155,436
233,169
Company pension contributions to defined contribution schemes
11,819
14,277
167,255
247,446
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 2 (2023 - 3).
Remuneration disclosed above includes the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
n/a
86,549
Company pension contributions to defined contribution schemes
n/a
7,426
As total directors' remuneration was less than £200,000 in the current year, no disclosure is provided for that year.
7
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
872
3,549
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 21 -
8
Interest payable and similar expenses
2024
2023
£
£
Interest on bank overdrafts and loans
207,918
189,111
Interest on finance leases and hire purchase contracts
29,596
23,058
Total finance costs
237,514
212,169
9
Taxation
2024
2023
£
£
Deferred tax
Origination and reversal of timing differences
(157,631)
(3,034)
Adjustment in respect of prior periods
86,384
Total deferred tax
(71,247)
(3,034)
The actual credit for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
Loss before taxation
(685,716)
(95,946)
Expected tax credit based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
(171,429)
(22,566)
Tax effect of expenses that are not deductible in determining taxable profit
5,174
(651)
Tax effect of income not taxable in determining taxable profit
(7,156)
Unutilised tax losses carried forward
2,511
Effect of change in corporation tax rate
-
81
Depreciation on assets not qualifying for tax allowances
17,591
Deferred tax adjustments in respect of prior years
86,384
Fixed asset differences
15,780
Taxation credit
(71,247)
(3,034)
A UK corporation tax rate of 25% was announced in the Chancellor’s Budget of 3 March 2021. The 25% rate applied from 1 April 2023 and deferred tax has been calculated at this rate.
10
Dividends
2024
2023
Recognised as distributions to equity holders:
£
£
Final paid
67,975
19,422
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 22 -
11
Intangible fixed assets
Group
Goodwill
Software
Total
£
£
£
Cost
At 1 January 2024
299,995
67,982
367,977
Additions
6,106
6,106
At 31 December 2024
299,995
74,088
374,083
Amortisation and impairment
At 1 January 2024
299,995
49,998
349,993
Amortisation charged for the year
12,986
12,986
At 31 December 2024
299,995
62,984
362,979
Carrying amount
At 31 December 2024
11,104
11,104
At 31 December 2023
17,984
17,984
Company
Software
£
Cost
At 1 January 2024
67,982
Additions
6,106
At 31 December 2024
74,088
Amortisation and impairment
At 1 January 2024
49,998
Amortisation charged for the year
12,986
At 31 December 2024
62,984
Carrying amount
At 31 December 2024
11,104
At 31 December 2023
17,984
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 23 -
12
Tangible fixed assets
Group
Freehold buildings
Leasehold improvements
Assets under construction
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
£
£
£
Cost
At 1 January 2024
3,456,008
293,121
54,344
7,136,335
10,104
139,271
299,876
11,389,059
Additions
112,426
28,597
22,311
3,431
5,778
163,310
335,853
Disposals
(4,037)
(15,066)
(465)
(9,475)
(29,043)
Transfers
(78,904)
78,904
At 31 December 2024
3,568,434
293,121
7,222,484
13,535
144,584
453,711
11,695,869
Depreciation and impairment
At 1 January 2024
341,799
254,592
5,080,715
9,039
77,619
281,093
6,044,857
Depreciation charged in the year
63,118
13,912
312,089
1,051
17,618
35,160
442,948
Eliminated in respect of disposals
(15,066)
(465)
(9,475)
(25,006)
At 31 December 2024
404,917
268,504
5,377,738
10,090
94,772
306,778
6,462,799
Carrying amount
At 31 December 2024
3,163,517
24,617
1,844,746
3,445
49,812
146,933
5,233,070
At 31 December 2023
3,114,209
38,529
54,344
2,055,620
1,065
61,652
18,783
5,344,202
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
12
Tangible fixed assets
(Continued)
- 24 -
Company
Freehold buildings
Leasehold improvements
Assets under construction
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
£
£
£
Cost
At 1 January 2024
2,995,757
288,921
54,344
7,069,906
10,104
136,091
293,626
10,848,749
Additions
112,426
28,597
5,436
3,431
5,778
163,310
318,978
Disposals
(4,037)
(465)
(9,475)
(13,977)
Transfers
(78,904)
78,904
At 31 December 2024
3,108,183
288,921
7,154,246
13,535
141,404
447,461
11,153,750
Depreciation and impairment
At 1 January 2024
262,794
250,392
5,023,846
9,039
74,439
274,843
5,895,353
Depreciation charged in the year
52,068
13,912
309,063
1,051
17,618
35,160
428,872
Eliminated in respect of disposals
(465)
(9,475)
(9,940)
At 31 December 2024
314,862
264,304
5,332,909
10,090
91,592
300,528
6,314,285
Carrying amount
At 31 December 2024
2,793,321
24,617
1,821,337
3,445
49,812
146,933
4,839,465
At 31 December 2023
2,732,963
38,529
54,344
2,046,060
1,065
61,652
18,783
4,953,396
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
12
Tangible fixed assets
(Continued)
- 25 -
Freehold land and buildings with a carrying amount of £2,096,461 (2023: £2,076,564) have been pledged to secure borrowings of the company. The company is not allowed to pledge these assets as security for other borrowings or to sell them to another entity.
13
Fixed asset investments
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Investments in subsidiaries
14
100
100
Unlisted investments
550,000
550,000
550,000
550,000
550,000
550,000
550,100
550,100
Movements in fixed asset investments
Group
Investments
£
Cost or valuation
At 1 January 2024 and 31 December 2024
550,000
Carrying amount
At 31 December 2024
550,000
At 31 December 2023
550,000
Movements in fixed asset investments
Company
Shares in subsidiaries
Other investments
Total
£
£
£
Cost or valuation
At 1 January 2024 and 31 December 2024
100
550,000
550,100
Carrying amount
At 31 December 2024
100
550,000
550,100
At 31 December 2023
100
550,000
550,100
14
Subsidiaries
Details of the company's subsidiaries at 31 December 2024 are as follows:
Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
Seiont Nurseries Limited
188 Blackgate Lane, Tarleton, Preston, England PR4 6UU
Horticultural grower
Ordinary
100.00
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 26 -
15
Stocks
Group
Company
2024
2023
2024
2023
£
£
£
£
Raw materials and consumables
1,492,109
1,773,020
1,492,109
1,773,020
Finished goods and goods for resale
668,453
619,333
415,436
371,222
2,160,562
2,392,353
1,907,545
2,144,242
16
Debtors
Group
Company
2024
2023
2024
2023
Amounts falling due within one year:
£
£
£
£
Trade debtors
954,708
946,390
935,611
912,863
Amounts owed by group undertakings
-
-
213,323
167,668
Other debtors
602,512
348,019
595,819
347,406
Prepayments and accrued income
303,257
222,540
285,203
207,430
1,860,477
1,516,949
2,029,956
1,635,367
17
Creditors: amounts falling due within one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Bank loans and overdrafts
19
1,835,023
1,097,955
1,756,440
1,055,289
Obligations under finance leases
20
148,564
141,814
148,564
141,814
Trade creditors
2,395,120
2,459,488
2,338,121
2,387,970
Amounts owed to group undertakings
2,743
Other taxation and social security
58,976
73,779
52,741
66,670
Other creditors
175,880
345,720
135,959
315,395
Accruals and deferred income
202,478
322,801
150,014
280,685
4,816,041
4,441,557
4,581,839
4,250,566
18
Creditors: amounts falling due after more than one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Bank loans and overdrafts
19
1,210,300
1,342,725
798,055
906,908
Obligations under finance leases
20
177,825
196,397
177,825
196,397
Other borrowings
19
388,401
388,401
1,776,526
1,539,122
1,364,281
1,103,305
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
18
Creditors: amounts falling due after more than one year
(Continued)
- 27 -
Amounts included above which fall due after five years are as follows:
Payable by instalments
244,517
295,371
244,517
295,371
19
Loans and overdrafts
Group
Company
2024
2023
2024
2023
£
£
£
£
Bank loans
3,008,255
2,440,680
2,553,344
1,962,197
Bank overdrafts
37,068
1,151
Other loans
388,401
388,401
3,433,724
2,440,680
2,942,896
1,962,197
Payable within one year
1,835,023
1,097,955
1,756,440
1,055,289
Payable after one year
1,598,701
1,342,725
1,186,456
906,908
There is a debenture over all assets of Lovania Nurseries Limited and Seiont Nurseries Limited.
There is a legal charge dated 26th October 2012 over Birchcroft Nursery, Gill Lane, Preston, PR4 4SS.
There is a legal charge dated 18th August 2014 over Nook Farm, Holker Lane, Leyland, PR26 8LL.
There is a legal charge dated 8th January 2016 over Caer Glyddyn, Caernarfon, Gwynedd, LL55 2BB.
There is a legal charge dated 31st July 2018 over the land at Moss Lane, Hesketh Bank, Preston, PR4 6AA.
There is a legal charge dated 5th February 2021 over the land adjoining 242 Moss Lane, Hesketh Bank, Preston, PR4 6AE.
The group and company have a loan of £102,019 (2023: £121,279) repayable in 10 years from inception. Interest is charged at 2.39% over Base Rate.
The group and company have a loan of £370,947 (2023: £395,141) repayable over 227 monthly instalments. Interest is charged at 2% over Base Rate.
The group and company have a loan of £289,197 (2023: £315,857) repayable over 120 monthly instalments. Interest is charged at 3% over Base Rate.
The group and company have a loan of £191,181 (2023: £229,920) repayable over 120 monthly instalments. Interest is charged at 2.3% over Base Rate.
The group has a loan of £454,911 (2023: £478,483) repayable over 180 monthly instalments. Interest is charged at 2.25% over Base Rate.
The group and company have a seasonal loan of £1,600,000 (2023: £900,000) repayable in July 2025. Interest is charged at 3.40% over Base Rate.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 28 -
20
Finance lease obligations
Group
Company
2024
2023
2024
2023
£
£
£
£
Future minimum lease payments due under finance leases:
Within one year
148,564
141,814
148,564
141,814
In two to five years
177,825
196,397
177,825
196,397
326,389
338,211
326,389
338,211
Finance lease payments represent rentals payable by the company or group for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 5 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.
Finance lease obligations are secured over the assets to which they relate.
21
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:
Liabilities
Liabilities
2024
2023
Group
£
£
Accelerated capital allowances
490,484
420,385
Tax losses
(265,316)
(125,491)
Short term timing differences
(1,521)
-
223,647
294,894
Liabilities
Liabilities
2024
2023
Company
£
£
Accelerated capital allowances
487,320
422,772
Tax losses
(246,975)
(125,491)
Short term timing differences
(1,263)
-
239,082
297,281
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
21
Deferred taxation
(Continued)
- 29 -
Group
Company
2024
2024
Movements in the year:
£
£
Liability at 1 January 2024
294,894
297,281
Credit to profit or loss
(71,247)
(58,199)
Liability at 31 December 2024
223,647
239,082
The deferred tax liability set out above is expected to reverse within 4 years and relates to the utilisation of tax losses against future expected profits and accelerated capital allowances that are expected to mature within the same period.
22
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
78,425
98,013
A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.
Contributions of £6,085 (2023: £12,803) were outstanding at the year end.
23
Share capital
Group and company
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
2
2
2
2
24
Reserves
Profit and loss reserves
Profit and loss reserves represent cumulative profits and losses, net of distributions to shareholders.
25
Financial commitments, guarantees and contingent liabilities
There is a guarantee granted by KC Ball and the estate of KJ Ball for £750,000 for security pledged against the bank overdraft.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 30 -
26
Operating lease commitments
At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
40,291
36,674
40,291
36,674
Between two and five years
55,377
20,915
55,377
20,915
95,668
57,589
95,668
57,589
27
Related party transactions
At the year-end, the directors were owed £388,401 (2023: £74,035) by the group. One director had an overdrawn account as disclosed in note 28 of the accounts.
One of the relatives of Mr & Mrs K Ball (directors and controlling shareholders) was a tenant living in the farmhouse at Nook Farm, Holker Lane, Leyland near Chorley Lancashire. This is a company owned property. The annual rent charged in the year to 31 December 2024 was £nil (2023: £nil). The total unpaid at 31 December 2024 was £nil (2023: £87,159).
There are net amounts due from companies that are under common control of £95,698 (2023: amounts owed of £35,193).
There is an amount receivable from the Lovania Salads Partnership of £62,929 (2023: £152,929) and from the Ball Property Partnership of £8,121 (2023: £nil). The partnerships have members who are also directors that have control of this group.
There is a net amount receivable from Flavourfresh Salads Limited of £343,040 (2023: £350,000). The company has members who are also directors that have control of this group.
28
Directors' transactions
Advances or credits have been granted by the group to its directors as follows:
Description
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
K C Ball - Loan
-
(31,844)
(8,928)
41,293
521
(31,844)
(8,928)
41,293
521
29
Controlling party
The company is under the ultimate control of Mrs K C Ball and the estate of Mr K J Ball following his demise in March 2025.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 31 -
30
Cash (absorbed by)/generated from group operations
2024
2023
£
£
Loss after taxation
(614,469)
(92,912)
Adjustments for:
Taxation credited
(71,247)
(3,034)
Finance costs
237,514
212,169
Investment income
(872)
(3,549)
(Gain)/loss on disposal of tangible fixed assets
(7,300)
22
Amortisation and impairment of intangible assets
12,986
28,625
Depreciation and impairment of tangible fixed assets
442,948
556,977
Movements in working capital:
Decrease in stocks
231,791
509,393
(Increase)/decrease in debtors
(375,372)
20,647
Decrease in creditors
(263,455)
(319,428)
Cash (absorbed by)/generated from operations
(407,476)
908,910
31
Analysis of changes in net debt - group
1 January 2024
Cash flows
New finance leases
31 December 2024
£
£
£
£
Cash at bank and in hand
138,486
(135,528)
-
2,958
Bank overdrafts
(37,068)
-
(37,068)
138,486
(172,596)
-
(34,110)
Borrowings excluding overdrafts
(2,440,680)
(955,976)
-
(3,396,656)
Obligations under finance leases
(338,211)
175,132
(163,310)
(326,389)
(2,640,405)
(953,440)
(163,310)
(3,757,155)
2024-12-312024-01-01falsefalseCCH SoftwareCCH Accounts Production 2025.200Mr K J BallMr I LandMr L ChambersMr J G BallMr J G BallMrs K C Ballfalse03921428bus:Consolidated2024-01-012024-12-31039214282024-01-012024-12-3103921428bus:CompanySecretaryDirector12024-01-012024-12-3103921428bus:Director22024-01-012024-12-3103921428bus:Director42024-01-012024-12-3103921428bus:CompanySecretary12024-01-012024-12-3103921428bus:Director12024-01-012024-12-3103921428bus:Director32024-01-012024-12-3103921428bus:Director52024-01-012024-12-3103921428bus:RegisteredOffice2024-01-012024-12-31039214282024-12-3103921428bus:Consolidated2024-12-3103921428bus:Consolidated2023-01-012023-12-31039214282023-01-012023-12-3103921428core:OtherResidualIntangibleAssetsbus:Consolidated2024-12-3103921428core:OtherResidualIntangibleAssetsbus:Consolidated2023-12-3103921428core:OtherResidualIntangibleAssets2024-12-3103921428core:OtherResidualIntangibleAssets2023-12-3103921428core:Goodwillbus:Consolidated2024-12-3103921428core:ComputerSoftwarebus:Consolidated2024-12-3103921428core:Goodwillbus:Consolidated2023-12-3103921428core:ComputerSoftwarebus:Consolidated2023-12-3103921428bus:Consolidated2023-12-3103921428core:ComputerSoftware2024-12-3103921428core:ComputerSoftware2023-12-31039214282023-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-12-3103921428core:LeaseholdImprovementsbus:Consolidated2024-12-3103921428core:ConstructionInProgressAssetsUnderConstructionbus:Consolidated2024-12-3103921428core:PlantMachinerybus:Consolidated2024-12-3103921428core:FurnitureFittingsbus:Consolidated2024-12-3103921428core:ComputerEquipmentbus:Consolidated2024-12-3103921428core:MotorVehiclesbus:Consolidated2024-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-12-3103921428core:LeaseholdImprovementsbus:Consolidated2023-12-3103921428core:ConstructionInProgressAssetsUnderConstructionbus:Consolidated2023-12-3103921428core:PlantMachinerybus:Consolidated2023-12-3103921428core:FurnitureFittingsbus:Consolidated2023-12-3103921428core:ComputerEquipmentbus:Consolidated2023-12-3103921428core:MotorVehiclesbus:Consolidated2023-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-3103921428core:LeaseholdImprovements2024-12-3103921428core:ConstructionInProgressAssetsUnderConstruction2024-12-3103921428core:PlantMachinery2024-12-3103921428core:FurnitureFittings2024-12-3103921428core:ComputerEquipment2024-12-3103921428core:MotorVehicles2024-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3103921428core:LeaseholdImprovements2023-12-3103921428core:ConstructionInProgressAssetsUnderConstruction2023-12-3103921428core:PlantMachinery2023-12-3103921428core:FurnitureFittings2023-12-3103921428core:ComputerEquipment2023-12-3103921428core:MotorVehicles2023-12-3103921428core:ShareCapitalbus:Consolidated2024-12-3103921428core:ShareCapitalbus:Consolidated2023-12-3103921428core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-12-3103921428core:ShareCapital2024-12-3103921428core:ShareCapital2023-12-3103921428core:RetainedEarningsAccumulatedLosses2024-12-3103921428core:RetainedEarningsAccumulatedLosses2023-12-3103921428core:ShareCapitalbus:Consolidated2022-12-3103921428core:RetainedEarningsAccumulatedLossesbus:Consolidated2022-12-3103921428core:ShareCapital2022-12-3103921428core:RetainedEarningsAccumulatedLosses2022-12-3103921428bus:Consolidated2022-12-3103921428core:Goodwill2024-01-012024-12-3103921428core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3103921428core:ComputerSoftware2024-01-012024-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3103921428core:LeaseholdImprovements2024-01-012024-12-3103921428core:PlantMachinery2024-01-012024-12-3103921428core:FurnitureFittings2024-01-012024-12-3103921428core:ComputerEquipment2024-01-012024-12-3103921428core:MotorVehicles2024-01-012024-12-3103921428bus:Consolidated12024-01-012024-12-3103921428bus:Consolidated12023-01-012023-12-3103921428core:Goodwillbus:Consolidated2023-12-3103921428core:ComputerSoftwarebus:Consolidated2023-12-3103921428bus:Consolidated2023-12-3103921428core:ComputerSoftware2023-12-3103921428core:Goodwillcore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3103921428core:ComputerSoftwarecore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3103921428core:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-01-012024-12-3103921428core:ComputerSoftwarecore:ExternallyAcquiredIntangibleAssets2024-01-012024-12-3103921428core:Goodwillbus:Consolidated2024-01-012024-12-3103921428core:ComputerSoftwarebus:Consolidated2024-01-012024-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-12-3103921428core:LeaseholdImprovementsbus:Consolidated2023-12-3103921428core:ConstructionInProgressAssetsUnderConstructionbus:Consolidated2023-12-3103921428core:PlantMachinerybus:Consolidated2023-12-3103921428core:FurnitureFittingsbus:Consolidated2023-12-3103921428core:ComputerEquipmentbus:Consolidated2023-12-3103921428core:MotorVehiclesbus:Consolidated2023-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3103921428core:LeaseholdImprovements2023-12-3103921428core:ConstructionInProgressAssetsUnderConstruction2023-12-3103921428core:PlantMachinery2023-12-3103921428core:FurnitureFittings2023-12-3103921428core:ComputerEquipment2023-12-3103921428core:MotorVehicles2023-12-31039214282023-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-01-012024-12-3103921428core:LeaseholdImprovementsbus:Consolidated2024-01-012024-12-3103921428core:ConstructionInProgressAssetsUnderConstructionbus:Consolidated2024-01-012024-12-3103921428core:PlantMachinerybus:Consolidated2024-01-012024-12-3103921428core:FurnitureFittingsbus:Consolidated2024-01-012024-12-3103921428core:ComputerEquipmentbus:Consolidated2024-01-012024-12-3103921428core:MotorVehiclesbus:Consolidated2024-01-012024-12-3103921428core:ConstructionInProgressAssetsUnderConstruction2024-01-012024-12-3103921428core:UnlistedNon-exchangeTradedbus:Consolidated2024-12-3103921428core:UnlistedNon-exchangeTradedbus:Consolidated2023-12-3103921428core:UnlistedNon-exchangeTraded2024-12-3103921428core:UnlistedNon-exchangeTraded2023-12-3103921428core:Subsidiary12024-01-012024-12-3103921428core:Subsidiary112024-01-012024-12-3103921428core:CurrentFinancialInstruments2024-12-3103921428core:CurrentFinancialInstruments2023-12-3103921428core:CurrentFinancialInstrumentsbus:Consolidated2024-12-3103921428core:CurrentFinancialInstrumentsbus:Consolidated2023-12-3103921428core:WithinOneYearbus:Consolidated2024-12-3103921428core:WithinOneYearbus:Consolidated2023-12-3103921428core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3103921428core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3103921428core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-12-3103921428core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2023-12-3103921428core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3103921428core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3103921428core:Non-currentFinancialInstrumentsbus:Consolidated2024-12-3103921428core:Non-currentFinancialInstrumentsbus:Consolidated2023-12-3103921428core:Non-currentFinancialInstruments2024-12-3103921428core:Non-currentFinancialInstruments2023-12-3103921428core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-12-3103921428core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2023-12-3103921428core:WithinOneYear2024-12-3103921428core:WithinOneYear2023-12-3103921428core:BetweenTwoFiveYearsbus:Consolidated2024-12-3103921428core:BetweenTwoFiveYearsbus:Consolidated2023-12-3103921428core:BetweenTwoFiveYears2024-12-3103921428core:BetweenTwoFiveYears2023-12-3103921428bus:PrivateLimitedCompanyLtd2024-01-012024-12-3103921428bus:FRS1022024-01-012024-12-3103921428bus:Audited2024-01-012024-12-3103921428bus:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3103921428bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP